171 related articles for article (PubMed ID: 10546010)
1. Optimized autoantibody-based risk assessment in family members. Implications for future intervention trials.
Bingley PJ; Williams AJ; Gale EA
Diabetes Care; 1999 Nov; 22(11):1796-801. PubMed ID: 10546010
[TBL] [Abstract][Full Text] [Related]
2. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives.
Bingley PJ; Christie MR; Bonifacio E; Bonfanti R; Shattock M; Fonte MT; Bottazzo GF; Gale EA
Diabetes; 1994 Nov; 43(11):1304-10. PubMed ID: 7926304
[TBL] [Abstract][Full Text] [Related]
3. Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers.
Bingley PJ; Bonifacio E; Williams AJ; Genovese S; Bottazzo GF; Gale EA
Diabetes; 1997 Nov; 46(11):1701-10. PubMed ID: 9356015
[TBL] [Abstract][Full Text] [Related]
4. Islet cell antibodies are less predictive of IDDM among unaffected children in the general population than in sibs of children with diabetes. The Childhood Diabetes in Finland Study Group.
Knip M; Karjalainen J; Akerblom HK
Diabetes Care; 1998 Oct; 21(10):1670-3. PubMed ID: 9773728
[TBL] [Abstract][Full Text] [Related]
5. The combination of antibodies to GAD-65 and IA-2ic can replace the islet-cell antibody assay to identify subjects at risk of type 1 diabetes mellitus.
Hatziagelaki E; Jaeger C; Petzoldt R; Seissler J; Scherbaum WA; Federlin K; Bretzel RG
Horm Metab Res; 1999 Oct; 31(10):564-9. PubMed ID: 10596966
[TBL] [Abstract][Full Text] [Related]
6. GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives.
Dittler J; Seidel D; Schenker M; Ziegler AG
Diabetes; 1998 Apr; 47(4):592-7. PubMed ID: 9568692
[TBL] [Abstract][Full Text] [Related]
7. Two-step islet autoantibody screening for risk assessment of type 1 diabetes in relatives.
Pastore MR; Bazzigaluppi E; Bonfanti R; Dozio N; Sergi A; Balini A; Belloni C; Meschi F; Bonifacio E; Bosi E
Diabetes Care; 1998 Sep; 21(9):1445-50. PubMed ID: 9727889
[TBL] [Abstract][Full Text] [Related]
8. Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies.
Pietropaolo M; Yu S; Libman IM; Pietropaolo SL; Riley K; LaPorte RE; Drash AL; Mazumdar S; Trucco M; Becker DJ
Pediatr Diabetes; 2005 Dec; 6(4):184-92. PubMed ID: 16390386
[TBL] [Abstract][Full Text] [Related]
9. The Giessen-Bad Oeynhausen family study: improved prediction of type I diabetes in a low incidence population of relatives using combinations of islet autoantibodies in a dual step model.
Jaeger C; Hatziagelaki E; Stroedter A; Becker F; Scherer S; Petzoldt R; Federlin K; Bretzel RG
Exp Clin Endocrinol Diabetes; 1999; 107(8):496-505. PubMed ID: 10612480
[TBL] [Abstract][Full Text] [Related]
10. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies.
Verge CF; Gianani R; Kawasaki E; Yu L; Pietropaolo M; Jackson RA; Chase HP; Eisenbarth GS
Diabetes; 1996 Jul; 45(7):926-33. PubMed ID: 8666144
[TBL] [Abstract][Full Text] [Related]
11. Associations of anti-GAD antibodies with islet cell antibodies and insulin autoantibodies in first-degree relatives of type I diabetic patients.
Roll U; Christie MR; Standl E; Ziegler AG
Diabetes; 1994 Jan; 43(1):154-60. PubMed ID: 8262311
[TBL] [Abstract][Full Text] [Related]
12. Validity of screening for individuals at risk for type I diabetes by combined analysis of antibodies to recombinant proteins.
Christie MR; Roll U; Payton MA; Hatfield EC; Ziegler AG
Diabetes Care; 1997 Jun; 20(6):965-70. PubMed ID: 9167107
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies to a 38-kDa glycosylated islet cell membrane-associated antigen in (pre)type 1 diabetes: association with IA-2 and islet cell autoantibodies.
Winnock F; Christie MR; Batstra MR; Aanstoot HJ; Weets I; Decochez K; Jopart P; Nicolaij D; Gorus FK;
Diabetes Care; 2001 Jul; 24(7):1181-6. PubMed ID: 11423499
[TBL] [Abstract][Full Text] [Related]
14. Combined analysis of islet cell antibodies that cross-react with mouse pancreas, antibodies to the M(r) 64,000 islet protein, and antibodies to glutamate decarboxylase in type I diabetic patients.
Chaillous L; Delamaire M; Martignat L; Maugendre D; Marre M; Mathieu E; Limal JM; Charbonnel B; Allannic H; Saï P
Diabetes Care; 1994 Oct; 17(10):1115-23. PubMed ID: 7821130
[TBL] [Abstract][Full Text] [Related]
15. Islet autoantibodies, nationality and gender: a multinational screening study in first-degree relatives of patients with Type I diabetes.
Williams AJ; Bingley PJ; Moore WP; Gale EA;
Diabetologia; 2002 Feb; 45(2):217-23. PubMed ID: 11935153
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of the importance of antibodies against islet cells (ICA) and Glutamate Decarboxylase(anti-GAD) for determining prognosis of diabetes type 1 in the Polish population--5 year observation].
Kretowski A; Szelachowska M; Kinalska I
Pol Arch Med Wewn; 1999 Apr; 101(4):323-7. PubMed ID: 10740410
[TBL] [Abstract][Full Text] [Related]
17. Combination of autoantibody markers and risk for development of type 1 diabetes: results from a large french cohort of family members.
Thivolet C; Nicolino M; Monbeig S; Estour B; Halimi S; Robert M; Orgiazzi J; Chatelain P;
Diabetes Metab; 2002 Sep; 28(4 Pt 1):279-85. PubMed ID: 12442065
[TBL] [Abstract][Full Text] [Related]
18. Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop.
Verge CF; Stenger D; Bonifacio E; Colman PG; Pilcher C; Bingley PJ; Eisenbarth GS
Diabetes; 1998 Dec; 47(12):1857-66. PubMed ID: 9836516
[TBL] [Abstract][Full Text] [Related]
19. Relationship of beta-cell function and autoantibodies to progression and nonprogression of subclinical type 1 diabetes: follow-up of the Seattle Family Study.
Greenbaum CJ; Sears KL; Kahn SE; Palmer JP
Diabetes; 1999 Jan; 48(1):170-5. PubMed ID: 9892239
[TBL] [Abstract][Full Text] [Related]
20. Progression to diabetes in relatives with islet autoantibodies. Is it inevitable?
Gardner SG; Gale EA; Williams AJ; Gillespie KM; Lawrence KE; Bottazzo GF; Bingley PJ
Diabetes Care; 1999 Dec; 22(12):2049-54. PubMed ID: 10587841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
